Clinical Trials Browser

Interventional × Neoplasms, Unknown Primary × Surveys and Questionnaires × Clear all

NCT01624220 2023-12-05

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT00353145 2012-08-02

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Phase 2 Completed

29 enrolled

Tumor-Agnostic

Neoplasms, Unknown Primary